Hepatozelluläres Karzinom (HCC): A Growing Global Health Concern

The hepatozelluläres Karzinom (HCC) is the fifth most common tumor worldwide, and its incidence is expected to continue rising globally. This is attributed to the increasing number of patients with non-alcoholic steatohepatitis, as well as the persistent high number of patients with alcoholic liver disease and chronic viral hepatitis.

New Insights and Advancements in HCC Diagnosis and Treatment

Since the first edition of this monograph, numerous new findings have been discovered, some of which have already been practically implemented, influencing the diagnosis and treatment of HCC. In this revised edition, renowned international experts have compiled current and clinically relevant study data, research results, and personal experiences to present a comprehensive overview of HCC.

This book aims to provide healthcare professionals and individuals interested in HCC with a detailed understanding of the latest developments in the field. The publication includes contributions from leading experts in the field, offering valuable insights into the diagnosis, treatment, and management of HCC.

With 128 pages of in-depth information, this book is an essential resource for anyone seeking to stay up-to-date with the latest advancements in HCC research and treatment.

Publication details:

Publisher: UNI-MED

Edition: 2, revised edition

Publication date: 10 May 2019

Language: German

Format: Hardcover

Pages: 128

ISBN-10: 3837423964

ISBN-13: 978-3837423969